Users Discontinuing Weight-Loss Injections Regain Pounds Four Times Faster Compared to People Using Diet and Exercise

Illustration of pharmaceutical syringe and scale
Weight management often requires ongoing approaches.

New research indicates that people who come off popular weight-loss injections like Wegovy and Mounjaro may regain shed pounds much more quickly than those who halt traditional lifestyle regimens.

Findings released in a prominent medical journal points out that while overweight individuals can lose about a fifth of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month once they quit.

"Users buying these medications must be aware of the risk of rapid rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.

This pace of recovery implies a reversion to pre-treatment mass in about 18 months.

Weighing Therapies

The research, which reviewed dozens of studies involving thousands of patients, compared the effects of these new drugs with conventional dieting.

Researchers note that individuals who lose weight through lifestyle changes alone usually have a slower creep back—around 100 grams monthly—post-intervention.

Explaining the Fast Regain

Nutrition scientists propose the way of the drugs is key to understanding the amplified weight return.

These medications mimic a body's own chemical called GLP-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 levels far above than normal might result in the system to produce less of its own natural hormone, and could lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this hormone supplement leads to hunger is unsuppressed, making excessive eating far more likely."

A Lifelong Condition?

The NHS advise the injections for people with obesity-related health risks, alongside recommended lifestyle changes.

Professionals contend that, given the high risk of relapse, the therapy is often ongoing.

This opinion is reinforced by pharmaceutical companies, who state that the results "emphasize the long-term nature of excess weight," similar to managing diseases like diabetes.

User Testimonies

Users who have discontinued the medication explain a sudden return of cravings.

"I experienced a trigger flipping and you're instantly ravenous," said a patient.

The struggle is exacerbated if individuals have not adopted sustainable dietary or behavioural modifications during treatment.

Growing Adoption

Recent estimates indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with desire remaining high.

  • Use is greater among females than men.
  • The 40s and 50s age group shows the greatest level of interest.
  • Many access the drugs through private prescriptions rather than the NHS.

Finally, clinicians emphasize that while these medications are effective agents for weight loss, they are not a permanent solution and long-term success likely depends on combined lifestyle support.

Crystal Hartman
Crystal Hartman

A software engineer and tech writer passionate about AI ethics and open-source projects, with over a decade of industry experience.